Key result
Sleeve gastrectomy linked to ~63% excess weight loss and metabolic syndrome resolution at 12 months.
Why the study?
Obesity and its correlation with metabolic syndrome increase the risk of major cardiovascular complications, and the effects of laparoscopic sleeve gastrectomy on metabolic parameters need evaluation.
Does laparoscopic sleeve gastrectomy improve weight and metabolic parameters in patients with morbid obesity and metabolic syndrome?
Population
23 patients with morbid obesity and metabolic syndrome
Comparison
Preoperative versus postoperative metabolic and anthropometric parameters
Design
Cohort study with multidisciplinary evaluation
Follow-up
12 months
Authors
Loading...
May support LSG consideration in morbid obesity with metabolic syndrome; leaves open durability and generalizability in RCTs.
Cohort (n=23)
Does laparoscopic sleeve gastrectomy improve weight and metabolic parameters in patients with morbid obesity and metabolic syndrome?
Laparoscopic sleeve gastrectomy is associated with significant weight loss and resolution of metabolic syndrome in patients with morbid obesity at 12 months.
Desiderio et al. (2013) conducted a cohort in Morbid obesity and metabolic disorders (n=23). Laparoscopic sleeve gastrectomy was evaluated on Excess weight loss at 12 months. Laparoscopic sleeve gastrectomy resulted in a mean excess weight loss of 62.59% at 12 months, with 22 of 23 patients no longer meeting criteria for metabolic syndrome.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: